The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 91 results:
Author Title Type [ Year(Asc)]
Filters: Keyword is Hypoglycemic Agents  [Clear All Filters]
2021
Tsapas, A., Karagiannis T., Avgerinos I., Matthews D. R., & Bekiari E. (2021).  Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes.. Ann Intern Med. 174(1), 141.
Avgerinos, I., Manolopoulos A., Michailidis T., Kitsios K., Liakos A., Karagiannis T., et al. (2021).  Comparative efficacy and safety of glucose-lowering drugs as adjunctive therapy for adults with type 1 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(3), 822-831.
Tsapas, A., Karagiannis T., Kakotrichi P., Avgerinos I., Mantsiou C., Tousinas G., et al. (2021).  Comparative efficacy of glucose-lowering medications on body weight and blood pressure in patients with type 2 diabetes: A systematic review and network meta-analysis.. Diabetes Obes Metab. 23(9), 2116-2124.
Tsapas, A., Karagiannis T., Avgerinos I., Liakos A., & Bekiari E. (2021).  GLP-1 receptor agonists for cardiovascular outcomes with and without metformin. A systematic review and meta-analysis of cardiovascular outcomes trials.. Diabetes Res Clin Pract. 177, 108921.
Kyriakidou, A., Koufakis T., Goulis D. G., Vasilopoulos Y., Zebekakis P., & Kotsa K. (2021).  Pharmacogenetics of the Glucagon-like Peptide-1 Receptor Agonist Liraglutide: A Step Towards Personalized Type 2 Diabetes Management.. Curr Pharm Des. 27(8), 1025-1034.
Avgerinos, I., Papanastasiou G., Karagiannis T., Michailidis T., Liakos A., Mainou M., et al. (2021).  Ultra-rapid-acting insulins for adults with diabetes: A systematic review and meta-analysis.. Diabetes Obes Metab. 23(10), 2395-2401.
2019
Paschou, S. A., Anagnostis P., Pavlou D. I., Vryonidou A., Goulis D. G., & Lambrinoudaki I. (2019).  Diabetes in Menopause: Risks and Management.. Curr Vasc Pharmacol. 17(6), 556-563.
Pantelidis, P., Tsitsopoulos P. P., Pappa E., Theologou E., Karanikolas N., Drosos C., et al. (2019).  The effect of diabetes mellitus on in-hospital hyperglycemia, length of stay and survival in patients with brain tumor receiving dexamethasone: A descriptive and comparative analysis.. Clin Neurol Neurosurg. 184, 105450.
Piperidou, A., Sarafidis P., Boutou A., Thomopoulos C., Loutradis C., Alexandrou M. Eleni, et al. (2019).  The effect of SGLT-2 inhibitors on albuminuria and proteinuria in diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.. J Hypertens. 37(7), 1334-1343.
Sarafidis, P., Ferro C. J., Morales E., Ortiz A., Malyszko J., Hojs R., et al. (2019).  SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.. Nephrol Dial Transplant. 34(2), 208-230.
Georgianos, P. I., Divani M., Eleftheriadis T., Mertens P. R., & Liakopoulos V. (2019).  SGLT-2 inhibitors in Diabetic Kidney Disease: What Lies Behind their Renoprotective Properties?. Curr Med Chem. 26(29), 5564-5578.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.